3 Top IBD 50 Stocks Hit New All-Time Highs

By | May 21, 2015

Scalper1 News

Three IBD 50 stocks are hitting new highs in the stock market today : Valeant Pharmaceuticals (VRX), Regeneron Pharmaceuticals (REGN) and NetEase (NTES). A Goldman Sachs report issued Thursday includes Valeant in the top 5 hedge fund long positions, along with Actavis (ACT), Apple (AAPL), Facebook (FB) and Microsoft (MSFT). And reports said Wednesday that Valeant is in advanced talks to buy Egyptian drugmaker Amoun Pharma. Valeant climbed 2.2% in Scalper1 News

Scalper1 News